552 related articles for article (PubMed ID: 8650190)
41. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
42. Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.
Kawao N; Tamura Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E278-88. PubMed ID: 24918201
[TBL] [Abstract][Full Text] [Related]
43. Pathogenesis of corneal epithelial defects: role of plasminogen activator.
Hayashi K; Berman M; Smith D; el-Ghatit A; Pease S; Kenyon KR
Curr Eye Res; 1991 May; 10(5):381-98. PubMed ID: 1909616
[TBL] [Abstract][Full Text] [Related]
44. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor.
Montuori N; Salzano S; Rossi G; Ragno P
FEBS Lett; 2000 Jul; 476(3):166-70. PubMed ID: 10913606
[TBL] [Abstract][Full Text] [Related]
45. Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.
Rakic JM; Lambert V; Munaut C; Bajou K; Peyrollier K; Alvarez-Gonzalez ML; Carmeliet P; Foidart JM; Noël A
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1732-9. PubMed ID: 12657615
[TBL] [Abstract][Full Text] [Related]
46. Spitz naevi may express components of the plasminogen activation system.
Ferrier CM; Van Geloof WL; Straatman H; Van De Molengraft FJ; Van Muijen GN; Ruiter DJ
J Pathol; 2002 Sep; 198(1):92-9. PubMed ID: 12210068
[TBL] [Abstract][Full Text] [Related]
47. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis.
Kitching AR; Holdsworth SR; Ploplis VA; Plow EF; Collen D; Carmeliet P; Tipping PG
J Exp Med; 1997 Mar; 185(5):963-8. PubMed ID: 9120402
[TBL] [Abstract][Full Text] [Related]
48. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
49. The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice.
Kawao N; Tamura Y; Horiuchi Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
PLoS One; 2015; 10(4):e0123982. PubMed ID: 25893677
[TBL] [Abstract][Full Text] [Related]
50. Urokinase plasminogen receptor and the fibrinolytic complex play a role in nerve repair after nerve crush in mice, and in human neuropathies.
Rivellini C; Dina G; Porrello E; Cerri F; Scarlato M; Domi T; Ungaro D; Del Carro U; Bolino A; Quattrini A; Comi G; Previtali SC
PLoS One; 2012; 7(2):e32059. PubMed ID: 22363796
[TBL] [Abstract][Full Text] [Related]
51. Renal urokinase-type plasminogen activator (uPA) receptor but not uPA deficiency strongly attenuates ischemia reperfusion injury and acute kidney allograft rejection.
Gueler F; Rong S; Mengel M; Park JK; Kiyan J; Kirsch T; Dumler I; Haller H; Shushakova N
J Immunol; 2008 Jul; 181(2):1179-89. PubMed ID: 18606671
[TBL] [Abstract][Full Text] [Related]
52. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
[TBL] [Abstract][Full Text] [Related]
53. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
[TBL] [Abstract][Full Text] [Related]
54. Fibrin affinity of urokinase-type plasminogen activator. Evidence that Zn2+ mediates strong and specific interaction of single-chain urokinase with fibrin.
Husain SS
J Biol Chem; 1993 Apr; 268(12):8574-9. PubMed ID: 8473303
[TBL] [Abstract][Full Text] [Related]
55. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice.
Hijazi N; Abu Fanne R; Abramovitch R; Yarovoi S; Higazi M; Abdeen S; Basheer M; Maraga E; Cines DB; Higazi AA
Blood; 2015 Apr; 125(16):2558-67. PubMed ID: 25673638
[TBL] [Abstract][Full Text] [Related]
56. Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice.
Cooper JM; Rastogi A; Krizo JA; Mintz EM; Prosser RA
Eur J Neurosci; 2017 Mar; 45(6):805-815. PubMed ID: 27992087
[TBL] [Abstract][Full Text] [Related]
57. Tissue plasminogen activator binding to mouse cerebellar granule neurons.
Verrall S; Seeds NW
J Neurosci Res; 1988; 21(2-4):420-5. PubMed ID: 3145983
[TBL] [Abstract][Full Text] [Related]
58. Role of plasminogen activators and urokinase receptor in platelet kinetics.
Piguet PF; Vesin C; Da Laperousaz C; Rochat A
Hematol J; 2000; 1(3):199-205. PubMed ID: 11920190
[TBL] [Abstract][Full Text] [Related]
59. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
60. Plasminogen activation by pro-urokinase in complex with its receptor--dependence on a tripeptide (Spectrozyme plasmin).
Wang J; Mazar A; Quan N; Schneider A; Henkin J
Eur J Biochem; 1997 Jul; 247(1):256-61. PubMed ID: 9249034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
